Champions Oncology Inc Cash Flow-to-Debt Ratio
Champions Oncology Inc cash flow-to-debt ratio. Champions Oncology Inc (CSBR) has a Cash Flow-to-Debt Ratio of -0.06x as of January 2026, meaning its operating cash flow of $-1.34 Million could theoretically repay 0% of its total liabilities ($24.07 Million) in one year. Check earnings quality score of Champions Oncology Inc to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Champions Oncology Inc (1996–2025)
Cash flow-to-debt ratio of Champions Oncology Inc from 1996 to 2025. Historical debt coverage capacity for Champions Oncology Inc across 30 annual periods. Check how aggressively does Champions Oncology Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Champions Oncology Inc Cash Flow-to-Debt Ratio by Year (1996–2025)
Champions Oncology Inc cash flow-to-debt ratio by year from 1996 to 2025. Year-by-year debt coverage analysis for Champions Oncology Inc. For the full cash flow conversion analysis, see cash flow conversion of Champions Oncology Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.26x | $7.39 Million | $28.57 Million | ▲ +218.1% |
| 2024 | -0.22x | $-6.14 Million | $28.04 Million | ▼ -264.2% |
| 2023 | 0.13x | $3.96 Million | $29.68 Million | ▼ -46.1% |
| 2022 | 0.25x | $6.50 Million | $26.28 Million | ▲ +396.5% |
| 2021 | -0.08x | $-1.68 Million | $20.16 Million | ▼ -144.9% |
| 2020 | 0.19x | $2.90 Million | $15.65 Million | ▼ -10.0% |
| 2019 | 0.21x | $1.86 Million | $9.03 Million | ▲ +236.3% |
| 2018 | -0.15x | $-1.23 Million | $8.10 Million | ▲ +59.5% |
| 2017 | -0.37x | $-2.84 Million | $7.61 Million | ▲ +68.0% |
| 2016 | -1.16x | $-6.45 Million | $5.54 Million | ▲ +51.8% |
| 2015 | -2.41x | $-9.63 Million | $3.99 Million | ▼ -298.8% |
| 2014 | -0.61x | $-3.43 Million | $5.67 Million | ▲ +41.9% |
| 2013 | -1.04x | $-4.26 Million | $4.09 Million | ▼ -143.3% |
| 2012 | -0.43x | $-5.23 Million | $12.20 Million | ▼ -9921.6% |
| 2011 | 0.00x | $-54.00K | $12.63 Million | ▲ +99.5% |
| 2010 | -0.89x | $-2.10 Million | $2.35 Million | ▼ -171.5% |
| 2009 | -0.33x | $-888.00K | $2.70 Million | ▼ -142.0% |
| 2008 | 0.78x | $792.40K | $1.01 Million | ▲ +543.0% |
| 2007 | -0.18x | $-78.47K | $444.82K | ▼ -26.0% |
| 2006 | -0.14x | $-93.97K | $671.05K | ▼ -149.1% |
| 2005 | -0.06x | $-35.60K | $633.34K | ▲ +62.2% |
| 2004 | -0.15x | $-72.05K | $484.62K | ▲ +58.2% |
| 2003 | -0.36x | $-248.12K | $696.91K | ▼ -761.3% |
| 2002 | -0.04x | $-32.68K | $790.69K | ▼ -120.7% |
| 2001 | 0.20x | $144.68K | $725.18K | ▲ +670.6% |
| 2000 | -0.03x | $-18.35K | $524.78K | ▼ -114.6% |
| 1999 | 0.24x | $110.00K | $460.00K | ▼ -77.8% |
| 1998 | 1.08x | $420.00K | $390.00K | ▲ +242.7% |
| 1997 | 0.31x | $110.00K | $350.00K | ▲ +424.8% |
| 1996 | -0.10x | $-30.00K | $310.00K | — |